DE3580140D1 - Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. - Google Patents

Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Info

Publication number
DE3580140D1
DE3580140D1 DE8585901459T DE3580140T DE3580140D1 DE 3580140 D1 DE3580140 D1 DE 3580140D1 DE 8585901459 T DE8585901459 T DE 8585901459T DE 3580140 T DE3580140 T DE 3580140T DE 3580140 D1 DE3580140 D1 DE 3580140D1
Authority
DE
Germany
Prior art keywords
active substances
products obtained
medicinal products
solving active
solving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585901459T
Other languages
English (en)
Inventor
Jerome Corbiere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3580140D1 publication Critical patent/DE3580140D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8585901459T 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. Expired - Lifetime DE3580140D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues

Publications (1)

Publication Number Publication Date
DE3580140D1 true DE3580140D1 (de) 1990-11-22

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585901459T Expired - Lifetime DE3580140D1 (de) 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Country Status (12)

Country Link
US (1) US4794117A (de)
EP (1) EP0173729B1 (de)
JP (1) JPS61501566A (de)
KR (1) KR930000029B1 (de)
AT (1) ATE57472T1 (de)
AU (1) AU573321B2 (de)
DE (1) DE3580140D1 (de)
HU (1) HU195918B (de)
IT (1) IT1200410B (de)
NO (1) NO165626C (de)
OA (1) OA08170A (de)
WO (1) WO1985004106A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
NZ226100A (en) * 1987-09-11 1990-12-21 Syntex Inc Stabilised ophthalmic formulation containing non-steroidal anti-inflammatory drug
DE436726T1 (de) * 1989-08-03 1992-02-06 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur photostabilisierung von augenspuelloesungen sowie photostabilisierte augenspuelloesung.
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
CA2196063A1 (en) * 1994-09-01 1996-03-07 Ching-Chiang Su Cosolvent parenteral formulation of tirilazad
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
EP1942902A1 (de) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Meloxicam enthaltende pharmazeutische zubereitung
JP2011510005A (ja) * 2008-01-18 2011-03-31 ダウ グローバル テクノロジーズ インコーポレイティド メトキシポリエチレングリコールを用いる難溶性活性物質の水溶解度増強方法
EP2394634B1 (de) * 2009-02-03 2018-11-21 Sunstar Inc. Hesperidinhaltige zusammensetzung
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
BR112013001508A2 (pt) * 2010-07-21 2016-06-07 Alcon Res Ltd composição farmacêutica com características de solubilidade intensificadas
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
EP0173729A1 (de) 1986-03-12
AU573321B2 (en) 1988-06-02
AU4064585A (en) 1985-10-11
JPS61501566A (ja) 1986-07-31
NO165626C (no) 1991-03-13
KR850700216A (ko) 1985-12-26
ATE57472T1 (de) 1990-11-15
OA08170A (fr) 1987-03-31
WO1985004106A1 (fr) 1985-09-26
NO165626B (no) 1990-12-03
NO854461L (no) 1985-11-08
IT8519873A0 (it) 1985-03-13
HU195918B (en) 1988-08-29
IT1200410B (it) 1989-01-18
HUT38263A (en) 1986-05-28
US4794117A (en) 1988-12-27
KR930000029B1 (ko) 1993-01-06
EP0173729B1 (de) 1990-10-17

Similar Documents

Publication Publication Date Title
DE3580140D1 (de) Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
FI953467A (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
YU69991A (sh) Derivati piridina
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
PL301582A1 (en) Substituted derivatives 4-phenyl-pyridonyl and 4-phenyl-2-alkoxy pyridine, method of obtaining such derivative and therapeutical agents containing them
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
FR2642065B1 (fr) Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FI92195C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
IT8424187A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT7924769A0 (it) Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante, processi per laloro preparazione e farmaci contenenti tali sostanze.
EP0271151A3 (de) Azumolen-Dosisformen
IT7827078A0 (it) Derivati di acidi 2-idrazono propionici n-sostituti, processi per la loro preparazione e farmaci che contengono tali sostanze.
HUT43793A (en) Process for production of medical and cosmetical compounds and their active substances
ATE133949T1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE65778T1 (de) 4-oxo-thiazolidin-2-yliden-acetamid-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel zur bekaempfung von erkrankungen des zentralnervensystems.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8380 Miscellaneous part iii

Free format text: IM HEFT 15/92, SEITE 4018, SP.3: DIE VEROEFFENTLICHUNG IST ZU STREICHEN

8339 Ceased/non-payment of the annual fee